Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2025/03/083378
CTRI/2025/03/083378
Not yet recruiting
Phase 2

A RANDOMIZED OPEN CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF BHARANGI NAGAR CHURNA WITH TANDULODAK IN TARUNI ASRUGDAR W.S.R. TO PUBERTY MENORRHAGIA

Dr Snehal Laxman Dongare1 site in 1 country100 target enrollmentStarted: March 30, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Dr Snehal Laxman Dongare
Enrollment
100
Locations
1
Primary Endpoint
To evaluate the efficacy of Bharangi Nagar churna with tandulodak in Taruni
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Overview

Brief Summary

This is randomised open controlled clinical trial to study the efficacy of bharangi nagar churna with tandulodak in taruni asrugdar in pubertal age group conducted at OPD no 8 and 15 of Yashwant dharmarth rugnalaya kodoli kolhapur. The result will be assess after 90 days of study.

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
13.00 Year(s) to 19.00 Year(s) (—)
Sex
Female

Inclusion Criteria

  • •1 Age 13 to 19 years unmarried girls 2 Patients with complaints of excessive bleeding per vagina during menstruation either in amount or duration 3 Polymenorrhagia 4 Patient with Hb 9gper dl or more than 9g per dl.

Exclusion Criteria

  • •1Known case of Endocrinal Disorder like Hypo or Hyperthyroidism PCOS 2 Known case of Bleeding Dyscrasias 3 Known case of Structural Abnormality in Genital Organ 4Known case of systemic disorders.

Outcomes

Primary Outcomes

To evaluate the efficacy of Bharangi Nagar churna with tandulodak in Taruni

Time Frame: 1st and 5th day of every cycle and after cessation of menses of every cycle for 3 consecutive cycles

Asrugdar W.S.R. to Puberty Menorrhagia.

Time Frame: 1st and 5th day of every cycle and after cessation of menses of every cycle for 3 consecutive cycles

Secondary Outcomes

  • 1. To reduce duration & amount of bleeding.(2. To assess improvement by parameters like PBAC.)

Investigators

Sponsor
Dr Snehal Laxman Dongare
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Snehal Laxman Dongare

Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 2/3
A study to check how well Rasanjanadi Churna works in treating diarrhea.
CTRI/2025/03/082630Dr Ompraksh Manohar Didpaye60
Not yet recruiting
Phase 1/2
To study efficacy of triphla churna with musta churna in the management of obesity
CTRI/2025/09/095275Sane Guruji Aarogya Kendra30
Not yet recruiting
Not Applicable
To evaluate the efficacy of Bhunimbadi Churna in nausea and vomiting during pregnancy
CTRI/2025/11/096902Dr Anumeha Sachan30
Not yet recruiting
Phase 2/3
ayurvedic treatment of amavata (rheumatoid arthritis)
CTRI/2025/02/080464Dr Anju S Raj132
Not yet recruiting
Phase 2/3
A Comparative Study Of Efficacy Of Chaturbeej Churna With Latakaranj Churna In The Management Of Garbhashay Shodhan
CTRI/2024/10/076031Tilak Ayurved Mahavidyalay50